[{"id":"4a644411-a00e-4214-bf86-6017965e452b","acronym":"FACT","url":"https://clinicaltrials.gov/study/NCT05546047","created_at":"2022-09-19T13:55:48.736Z","updated_at":"2024-07-02T16:36:01.576Z","phase":"Phase 4","brief_title":"A Study of Acthar Gel Alone or With Tacrolimus to Reduce Proteinuria in Fibrillary Glomerulopathy Patients","source_id_and_acronym":"NCT05546047 - FACT","lead_sponsor":"NephroNet, Inc.","biomarkers":" VEGFA • TGFB1 • PODXL","pipe":"","alterations":" ","tags":["VEGFA • TGFB1 • PODXL"],"overall_status":"Active, not recruiting","enrollment":" Enrollment 34","initiation":"Initiation: 03/14/2019","start_date":" 03/14/2019","primary_txt":" Primary completion: 10/27/2023","primary_completion_date":" 10/27/2023","study_txt":" Completion: 10/27/2024","study_completion_date":" 10/27/2024","last_update_posted":"2022-10-31"}]